Jing-Zhou Hou
- Hematology top 2%
- Acute Myeloid Leukemia Research 1
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research 1
-
- Acute Lymphoblastic Leukemia research 1
-
- Neutropenia and Cancer Infections 1
- CAR-T cell therapy research 1
-
- Lymphoma Diagnosis and Treatment 2
-
- Radiopharmaceutical Chemistry and Applications 1
-
- Lung Cancer Treatments and Mutations 1
- Co-authors
- Tu XuSuresh AgarwalRelja PopovicTara L. LinMichael R. SavonaAndrew H. WeiRoland B. WalterWalter Fiedler
- Journals
- Journal of Clinical Oncology (1 paper)Journal of Hematology & Oncology (1 paper)Clinical Nuclear Medicine (1 paper)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Jing-Zhou Hou
3 papers receiving 494 citations
Hit Papers
Peers
Comparison fields: 5 of 43
- Hematology 418
- Genetics 115
- Public Health, Environmental and Occupational Health 115
- Molecular Biology 268
- Oncology 99
Countries citing papers authored by Jing-Zhou Hou
This map shows the geographic impact of Jing-Zhou Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing-Zhou Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing-Zhou Hou more than expected).
Fields of papers citing papers by Jing-Zhou Hou
This network shows the impact of papers produced by Jing-Zhou Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing-Zhou Hou. The network helps show where Jing-Zhou Hou may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jing-Zhou Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 41 | |
| 2 | Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Studybreakdown → | 2019 | 456 |
| 3 | 2012 | 1 |
About Jing-Zhou Hou
Jing-Zhou Hou is a scholar working on Pathology and Forensic Medicine, Genetics and Hematology, having authored 3 papers that have together received 498 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (2 papers), Acute Myeloid Leukemia Research (1 paper), Neutropenia and Cancer Infections (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Acute Lymphoblastic Leukemia research (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), CAR-T cell therapy research (1 paper) and Lung Cancer Treatments and Mutations (1 paper). The work is most often cited by research in Hematology (418 citations), Genetics (115 citations) and Public Health, Environmental and Occupational Health (115 citations). Jing-Zhou Hou has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Tu Xu, Suresh Agarwal, Relja Popovic, Tara L. Lin, Michael R. Savona, Andrew H. Wei, Roland B. Walter, Walter Fiedler, Stephen A. Strickland and Sang‐Min Lee. Their work appears in journals such as Journal of Clinical Oncology, Journal of Hematology & Oncology and Clinical Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.